Log In
BCIQ
Print this Print this
 

Virulizin

  Manage Alerts
Collapse Summary General Information
Company Aptose Biosciences Inc.
DescriptionBovine bile extract to activate macrophages
Molecular Target Interleukin-25 (IL-25) (IL-17E)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic
Latest Stage of DevelopmentApproved
Standard IndicationMelanoma
Indication DetailsTreat malignant melanoma
Regulatory Designation
PartnerZoticon Bioventures

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$13.0M

$2.9M

0


 Deals Details
Get a free BioCentury trial today